Report on CDSCO functioning to be ready in three months
DCGI mulls rule to protect patients enrolled in clinical trials
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Phase I trial of CSIR-IMTECH’s clot buster to start by end October
Ahmedabad’s Veeda CR to conduct the trial, CSIR aims to launch drug in India by 2014
Merck acquires Biochrom
The acquisition will strengthen Merck Millipore’s Process Solutions business unit
Wockhardt gets US FDA approval for generic version of anti-hypertensive drug Plendil
Will manufacture the felodipine API in its facility at Ankleshwar
Venus Remedies launches Trois for arthritic pain
Trois is a patent protected topical nano emulsion with all natural ingredients and has no side effects
IPAB postpones hearing on Natco’s CL for Bayer’s Nexavar to Sept 3
Focus shifts to Novartis India's challenge to Section 3 (d), scheduled for tomorrow
US FDA clears Claris Lifesciences’ facility after remedial action
Approval allows Claris to re-enter US market
‘It is a critical time to capitalise on the biotech opportunities available within…
James C Greenwood, President and CEO, Biotechnology Industry Organisation (BIO) and a former Congressman from Pennsylvania, US…
CPhI Worldwide 2012 to raise success story of Indian pharma industry
Event to be held in Feria de Madrid, Spain from October 9 to 11, 2012
A clarion call to step up research for AIDS vaccine
India renews its commitment towards collaborative HIV vaccine research: DBT and IAVI set up a new lab devoted to the same